EirGenix Inc. (6589.TW) — Stock Score Summary

EirGenix Inc. (6589.TW) has a MoatMap StockRank of 19/100 based on Quality (38/100), Value (43/100), and Momentum (23/100) factor scores. The current signal is STRONG SELL. EirGenix is an emerging biologics CDMO and biosimilar developer in Taiwan. As global pharmaceutical companies actively seek to diversify their supply chains away from mainland Chinese CDMOs due to geopolitical tensions (e.g., the US Biosecure Act), EirGenix stands to capture spillover demand as a trusted regional partner.

EirGenix Inc. operates as a biologics CDMO and develops biosimilars, focusing on oncology treatments like trastuzumab biosimilars. The company combines a dual-engine business model of high-margin biosimilar development and stable CDMO service revenues. It is a premier biopharmaceutical company in Taiwan with EU GMP-certified mammalian cell culture facilities.

Key Financial Metrics

Price$1.40
Market Cap$407M
Price/Book1.64
Return on Equity-8.7%
Return on Invested Capital-7.7%
Debt/Equity18.51
Gross Margin21.4%
Operating Margin-67.2%
Revenue Growth69.5%
Free Cash Flow$-792K

EirGenix Inc. operates in the Biotechnology industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is EirGenix Inc.’s (6589.TW) StockRank?
MoatMap’s StockRank for EirGenix Inc. (6589.TW) is 19/100, with a Strong Sell signal. It is a composite of Quality (38), Value (43), and Momentum (23) factor ranks across MoatMap’s 19,000+ stock universe.
Does EirGenix Inc. have an economic moat?
EirGenix Inc. (6589.TW) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is EirGenix Inc. a buy, hold, or sell?
MoatMap’s current signal for EirGenix Inc. (6589.TW) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is EirGenix Inc. in?
EirGenix Inc. (6589.TW) operates in the Healthcare sector, specifically the Biotechnology industry (Taiwan).
Browse all ranked stocks6589.TW deep dive reportAI ChampionsHow we score stocksSense-check another stock